CNST
Constellation Pharmaceuticals, Inc.
CNST
CNST
Delisted
CNST was delisted on the 14th of July, 2021.
44 hedge funds and large institutions have $225M invested in Constellation Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+7
Holders Change %
+18.92%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
11
Increased
17
Reduced
7
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$8.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.69M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.18M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.07M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.03M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$5.18M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$406K |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$318K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$108K |
| 5 |
Morgan Stanley
New York
|
-$86.4K |
